Associate Director of Oncology Advocacy
Bristol Myers Squibb

As an immigrant from Nigeria, Dr. Osundina has a passion for global health equity, outcomes research, policy and advocacy. Dr. Osundina joined BMS in 2017 as the BMS Foundation Public Health Resident supporting the organization’s mission to promote health equity and improve the health outcomes of populations disproportionately affected by serious disease in sub-Saharan Africa and in the U.S. After completing her residency, Dr. Osundina joined the BMS US Oncology Patient Advocacy and Professional Relations team. 

In her current role, Dr. Osundina leads patient advocacy efforts supporting Lung, Mesothelioma, Head & Neck, and Glioblastoma cancers. She is also leading the US Advocacy Health Equity Strategy to ensure that every BMS advocacy initiative is considered through a Health Equity lens. Through collaborations with various internal matrix teams, Dr. Osundina works to evaluate opportunities and develop unique solutions that appropriately elevate the patient voice. Dr. Osundina has also made significant contributions to BMS’s overall Global Diversity & Inclusion initiatives through the People Business and Resource Group (PBRG) Clinical Trial Advisory Committee, as a member of the Black Organization for Leadership & Development (BOLD) leadership team and the Health Equity Initiative (HEI) Working Group. 

Dr. Osundina obtained her Bachelor of Science in Pharmaceutical Sciences, Masters in Health Outcomes and Socioeconomic Sciences and Doctorate of Pharmacy from the University of Toledo, in Ohio. She enjoys traveling, volunteering and spending time with family and friends.